Bajaj Healthcare Ltd

539872

Overview

    • Equity Style Box

      Small Blend

    • Sector

      Healthcare

    • Industry

      Drug Manufacturers - Specialty & Generic

    • Day Range

      425.00 – 432.00

    • Year Range

      333.20 – 744.90

    • Market Cap

      13.4955 Bil

    • Volume / Avg

      2.9 k / 16.1 k

    • Price / Sales

      2.39

    • Price / Book

      2.89

    • Price / Earnings

      28.71

    • Forward Div Yield

      0.23%

    • Trailing Div Yield

      0.23%

Login To Show Full Chart

Summary

Fair Value Assessment
Overvalued (8% Premium)
Fair ValueQ393.25UncertaintyHigh
Close Price426.70Sep 08, 2025
₹ 427.30
Price Up by 0.60 | 0.14 %
Trading Information Business Description
Previous Close
426.70
Day Range
425.00 – 432.00
Year Range
333.20 – 744.90
Bid / Ask
426.25 × 427.25
Market Cap
13.5 Bil
Volume / Average
2.9 k / 16.1 k
Beta (5-Year)
–
Shares Outstanding
31.58 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Bajaj Healthcare Ltd is an India-based pharmaceutical company that manufactures Active Pharmaceutical Ingredients (APIs), Intermediates, Finished Dosage Forms, and Nutraceuticals. Its products include Intermediates, API, Formulation, and Impurities. The company derives a majority of its revenue from India.
Contact
Road No. 23, Wagle Industrial Estate 602-606, Bhoomi Velocity Infotech Park, Thane, MH 400 604
T +91 2266177400
www.bajajhealth.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Jun 30, 2025
Fiscal Year End
Mar 31, 2025
Employees
1,570
As of Mar 31, 2024

Key Metrics

This table shows 5 and 10 year data from the company's income statement sheet.
Income Statement (in Bil, except ratios)
06/30/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Revenue
5.59 5.43 4.73 6.73 6.79 6.56
Revenue Growth %
17.50% 14.61% -26.69% -0.97% 3.57% 60.83%
Gross Profit
2.58 2.56 2.14 1.83 1.84 1.93
Gross Profit Margin %
46.09% 47.21% 45.26% 27.13% 27.07% 29.41%
Operating Income
0.56 0.55 0.49 0.82 1.04 1.21
Operating Margin %
9.94% 10.05% 10.29% 12.21% 15.33% 18.48%
EBIT
0.75 0.74 0.12 0.79 1.02 1.27
EBIT Margin %
13.42% 13.62% 2.55% 11.80% 15.06% 19.36%
EBITDA
1.02 1.02 0.43 1.07 1.20 1.43
EBITDA Margin %
18.22% 18.77% 9.19% 15.87% 17.66% 21.82%
Net Income
0.44 0.39 -0.84 0.43 0.71 0.83
Net Profit Margin %
8.42% 7.91% -3.03% 6.39% 10.51% 12.67%
Basic EPS
14.31 13.29 -30.36 15.59 25.87 30.12
Diluted EPS
14.04 13.12 -30.36 15.59 25.87 30.12
Normalized EPS
— — — — — —
Total Dividends per Share
1.00 1.00 1.00 1.50 1.00 0.88
This table shows 5 and 10 year data from the company's balance sheet.
Balance Sheet (in Bil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Total Assets
8.33 8.33 7.65 9.01 7.21 5.26
Total Liabilities
3.67 3.67 4.87 5.34 3.93 2.67
Total Debt
2.23 2.23 3.33 4.15 2.57 1.81
Total Equity
4.66 4.66 2.78 3.68 3.28 2.58
Cash And Cash Equivalents
0.03 0.03 0.02 0.18 0.02 0.14
Working Capital
2.64 2.64 0.29 0.74 0.76 0.76
Shares Outstanding (Mil)
— — — 27.60 — 27.60
Book Value Per Share
147.60 147.60 100.86 133.23 119.02 93.63
Total Debt To Equity
0.48 0.48 1.20 1.13 0.78 0.70
This table shows 5 and 10 year data from the company's cash flow statement.
Cash Flow Statement (in Bil, except ratios)
03/31/2025
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
0.22 0.92 -0.22 0.01 0.44 0.21
Cash From Investing Activities
-0.15 -0.11 -0.93 -0.75 -1.09 -0.28
Cash From Financing Activities
-0.06 -0.97 1.31 0.62 0.75 0.03
Capital Expenditures
0.12 0.30 1.24 0.79 1.14 0.23
Free Cash Flow
0.44 -0.18 -0.44 0.20 -0.14 0.13
Change in Cash
— -0.16 0.16 -0.12 0.10 -0.04

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
Oops!
Something went wrong.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
Oops!
Something went wrong.

Ownership

Ownership lists the Fund owners and Intitutional owners of the stock.
Name
Morningstar
Rating
% Total
Shares Held
% Total
Assets
Trend
Prev. 8 Qtrs
Current Shares
Change Amount
Change %
Date
HDFC Pharma and Healthcare Reg Gr Not Rated 1.66 1.32 524,562
414,200
375.31%
Jul 31, 2025
Avantis Emerging Markets Equity ETF 0.20 0.00 63,102
—
0.00%
Aug 30, 2025
Avantis® Emerging Markets Equity Instl 0.01 0.00 4,557
—
0.00%
Jul 31, 2025
Avantis Emerging Markets Ex-Chn Eq ETF Not Rated 0.01 0.01 3,342
—
0.00%
Aug 30, 2025
Avantis Responsible Emerging Mkts Eq ETF 0.01 0.01 2,301
—
0.00%
Aug 30, 2025
Total (for Top 5) 1.89 597,864
414,200
More Ownership Data

STOCKS
MUTUAL FUNDS
ADITYABIRLAANGELONEAXISBajajBANDHANBARODABNPBOICANARACAPITALMINDDSPEDELWEISSFRANKLINTEMPLETONGROWWHDFCHELIOSHSBCICICIIIFLINVESCOITIJIOBLACKROCKJMKOTAKLICMahindraManulifeMIRAEMOTILALNAVINipponNJOldBridgePGIMPPFASQUANTQUANTUMSAMCOSBISHRIRAMSUNDARAMTATATAURUSTrustUNIFIUNIONUTIWhiteOakZERODHA
INSURANCE FUNDS
ABSLAEGONAGEASFEDERALAVIVABAJAJALLIANZBHARTIAXACANARAHSBCORIENTBANKEDELWEISSTOKIOEXIDEFUTUREGENERALIHDFCICICIPRUDENTIALINDIAFIRSTKOTAKMAHINDRALICMAXLIFEPNBMETLIFEPRAMERICARELIANCENIPPONSAHARASBISHRIRAMSTARUNIONDAI-ICHITATAAIA

About Us

Connect With Us

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top